1. Home
  2. LAW vs BNTC Comparison

LAW vs BNTC Comparison

Compare LAW & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CS Disco Inc.

LAW

CS Disco Inc.

N/A

Current Price

$6.06

Market Cap

286.9M

Sector

Technology

ML Signal

N/A

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

N/A

Current Price

$9.43

Market Cap

344.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LAW
BNTC
Founded
2013
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
286.9M
344.4M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
LAW
BNTC
Price
$6.06
$9.43
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$8.00
★ $23.29
AVG Volume (30 Days)
★ 236.0K
179.7K
Earning Date
11-04-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 22.58
6.67
EPS
★ N/A
N/A
Revenue
★ $156,849,000.00
N/A
Revenue This Year
$12.74
N/A
Revenue Next Year
$10.55
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 8.29
N/A
52 Week Low
$2.45
$7.89
52 Week High
$9.11
$14.39

Technical Indicators

Market Signals
Indicator
LAW
BNTC
Relative Strength Index (RSI) 77.10 50.37
Support Level $3.93 $8.14
Resistance Level $6.39 $9.29
Average True Range (ATR) 0.29 0.63
MACD 0.05 0.17
Stochastic Oscillator 71.57 56.50

Price Performance

Historical Comparison
LAW
BNTC

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: